Patent Expiry
- शब्दकोश
- Patent expiry IP सुरक्षा समाप्त—अन्य निर्माता generic संस्करण बना सकते।
Semaglutide patent विकास से 2024–2026 मध्ये CDSCO-स्वीकृत generic, जेब से भुगतान करने वाले मधुमेह/मोटापा रुग्णां साठी affordability। भारतात ये अवधारणाएँ RSSDI आणि ICMR मार्गदर्शन मध्ये दिखती हैं—विवरण अपने प्रिस्क्राइबिंग वैद्य से पुष्टि करें।
Medically reviewed
Dr. Ananya Mehta, MD, DM Endocrinology
Consultant Endocrinologist, India
This article has been reviewed by our medical advisory team, including endocrinologists, internal medicine specialists, and cardiologists, and is based on current scientific evidence and Indian clinical guidelines. Last reviewed: June 2026.
Last medically reviewed: Jun 15, 2026